BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26305873)

  • 1. Understanding decisions made about hepatitis C treatment by couples who inject drugs.
    Treloar C; Rance J; Bryant J; Fraser S
    J Viral Hepat; 2016 Feb; 23(2):89-95. PubMed ID: 26305873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm reduction workers and the challenge of engaging couples who inject drugs in hepatitis C prevention.
    Treloar C; Rance J; Bryant J; Fraser S
    Drug Alcohol Depend; 2016 Nov; 168():170-175. PubMed ID: 27665209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Don't think I'm going to leave you over it": Accounts of changing hepatitis C status among couples who inject drugs.
    Rance J; Treloar C; Fraser S; Bryant J; Rhodes T
    Drug Alcohol Depend; 2017 Apr; 173():78-84. PubMed ID: 28208098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in injecting behaviour among people treated for hepatitis C virus: The role of intimate partnerships.
    Malaguti A; Sani F; Stephens BP; Ahmad F; Dugard P; Dillon JF;
    J Viral Hepat; 2019 Jan; 26(1):65-72. PubMed ID: 30260560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs.
    Treloar C; Hull P; Bryant J; Hopwood M; Grebely J; Lavis Y
    Drug Alcohol Depend; 2011 Jul; 116(1-3):52-6. PubMed ID: 21194852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge and attitudes towards hepatitis C and injecting drug use among mental-health support workers of a community managed organisation.
    Rose G; Cama E; Brener L; Treloar C
    Aust Health Rev; 2013 Nov; 37(5):654-9. PubMed ID: 24160716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia.
    Madden A; Hopwood M; Neale J; Treloar C
    Harm Reduct J; 2018 Aug; 15(1):42. PubMed ID: 30111327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
    Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
    J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. At the intersection of marginalised identities: lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion.
    Deacon RM; Mooney-Somers J; Treloar C; Maher L
    Health Soc Care Community; 2013 Jul; 21(4):402-10. PubMed ID: 23465052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Treloar C; Newland J; Rance J; Hopwood M
    J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment.
    Bouscaillou J; Champagnat J; Luhmann N; Avril E; Inaridze I; Miollany V; Labartkava K; Kirtadze I; Butsashvili M; Kamkamidze G; Pataut D
    Int J Drug Policy; 2014 Sep; 25(5):871-8. PubMed ID: 24529802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
    Treloar C; Hull P; Dore GJ; Grebely J
    Drug Alcohol Rev; 2012 Nov; 31(7):918-24. PubMed ID: 22612899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.
    Harris M; Rhodes T
    Drug Alcohol Depend; 2013 Oct; 132(3):617-23. PubMed ID: 23664125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Affording' new approaches to couples who inject drugs: A novel fitpack design for hepatitis C prevention.
    Fraser S; Treloar C; Gendera S; Rance J
    Int J Drug Policy; 2017 Dec; 50():19-35. PubMed ID: 28982041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study.
    Alavi M; Micallef M; Fortier E; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Grebely J;
    J Viral Hepat; 2015 Nov; 22(11):914-25. PubMed ID: 25996567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.
    Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S62-9. PubMed ID: 23884068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
    Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
    Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study.
    Fortier E; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Bruneau J; Grebely J;
    Int J Drug Policy; 2015 Nov; 26(11):1094-102. PubMed ID: 26145482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.